<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on November 19, 2021</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT04693871</url>
  </required_header>
  <id_info>
    <org_study_id>XieRuiqinLAAEV</org_study_id>
    <nct_id>NCT04693871</nct_id>
  </id_info>
  <brief_title>Effect of Left Atrial Appendage Velocity on Left Atrial Structure and Function After Radiofrequency Ablation Combined With Left Atrial Appendage Occlusion</brief_title>
  <official_title>Effect of Left Atrial Appendage Velocity on Left Atrial Structure and Function After Radiofrequency Ablation Combined With Left Atrial Appendage Occlusion.</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>The Second Hospital of Hebei Medical University</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>The Second Hospital of Hebei Medical University</source>
  <oversight_info>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>Yes</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      Radiofrequency ablation of atrial fibrillation combined with left atrial appendage closure&#xD;
      can not only improve symptoms in patients with non-valvular atrial fibrillation, but also&#xD;
      prevent left atrial appendage thrombosis. The safety and effectiveness of left atrial&#xD;
      appendage occlusion have been confirmed by randomized controlled trials and actual&#xD;
      experience. Among patients with different left atrial appendage emptying speeds, there are&#xD;
      limited studies on the structure and function of the left atrial appendage after LAA closure.&#xD;
      In this study, patients with persistent nonvalvular atrial fibrillation were selected for&#xD;
      radiofrequency ablation combined with LAA closure. The sinus rhythm was restored after the&#xD;
      operation. According to the different emptying speed of the left atrial appendage, they were&#xD;
      divided into a high-flow rate group and a low-flow rate group. The differences in the&#xD;
      structure and function of the left atrium between the two groups were analyzed.&#xD;
    </textblock>
  </brief_summary>
  <overall_status>Completed</overall_status>
  <start_date type="Actual">January 1, 2020</start_date>
  <completion_date type="Actual">January 1, 2021</completion_date>
  <primary_completion_date type="Actual">January 1, 2021</primary_completion_date>
  <study_type>Observational</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <observational_model>Case-Control</observational_model>
    <time_perspective>Prospective</time_perspective>
  </study_design_info>
  <primary_outcome>
    <measure>Changes in the structure of the left atrium</measure>
    <time_frame>1year</time_frame>
    <description>Measure the left atrial transverse diameter, anteroposterior diameter, upper and lower diameter.</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Changes in the function of the left atrium</measure>
    <time_frame>1year</time_frame>
    <description>Left atrium volume. Two-chamber and four-chamber left atrium strain and strain rate, left atrium storage function, channel function and pump function.</description>
  </primary_outcome>
  <number_of_groups>2</number_of_groups>
  <enrollment type="Actual">100</enrollment>
  <condition>Left Atrial Appendage Velocity</condition>
  <condition>Left Atrial Structure</condition>
  <condition>Left Atrial Function</condition>
  <arm_group>
    <arm_group_label>high-flow rate group</arm_group_label>
  </arm_group>
  <arm_group>
    <arm_group_label>low-flow rate group</arm_group_label>
  </arm_group>
  <intervention>
    <intervention_type>Device</intervention_type>
    <intervention_name>Transesophageal ultrasound</intervention_name>
    <description>Patients with nonvalvular atrial fibrillation underwent radiofrequency ablation combined with left atrial appendage closure and recovered to sinus rhythm after the operation. To study the changes of left atrial organization and function of two groups of patients with different left atrial appendage emptying speeds.</description>
    <arm_group_label>high-flow rate group</arm_group_label>
    <arm_group_label>low-flow rate group</arm_group_label>
    <other_name>Radiofrequency ablation of atrial fibrillation combined with left atrial appendage closure</other_name>
  </intervention>
  <eligibility>
    <study_pop>
      <textblock>
        Patients with non-valvular atrial fibrillation between the ages of 18 and 80 received&#xD;
        atrial fibrillation radiofrequency ablation combined with left atrial appendage occlusion,&#xD;
        and recovered to sinus rhythm after the operation. According to the different left atrial&#xD;
        appendage emptying speed, it is divided into a higher left atrial appendage emptying speed&#xD;
        group and a lower left atrial appendage emptying speed group.&#xD;
      </textblock>
    </study_pop>
    <sampling_method>Probability Sample</sampling_method>
    <criteria>
      <textblock>
        Inclusion Criteria:&#xD;
&#xD;
          -  Patients who received atrial fibrillation radiofrequency ablation combined with left&#xD;
             atrial appendage closure.&#xD;
&#xD;
        Exclude Criteria&#xD;
&#xD;
          -  Patients with incomplete data.&#xD;
&#xD;
          -  Device embolism.&#xD;
&#xD;
          -  Residual shunt around the device found by transesophageal echocardiography greater&#xD;
             than 5 mm.&#xD;
&#xD;
          -  Mitral valve stenosis.&#xD;
&#xD;
          -  Artificial valve.&#xD;
&#xD;
          -  Atrial septal defect.&#xD;
&#xD;
          -  Dilated cardiomyopathy&#xD;
&#xD;
          -  Moderate Severe mitral regurgitation&#xD;
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>80 Years</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <location>
    <facility>
      <name>The Second Hospital of Hebei Medical University</name>
      <address>
        <city>Shijiazhuang</city>
        <state>Hebei</state>
        <zip>050000</zip>
        <country>China</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>China</country>
  </location_countries>
  <verification_date>January 2020</verification_date>
  <study_first_submitted>December 10, 2020</study_first_submitted>
  <study_first_submitted_qc>December 30, 2020</study_first_submitted_qc>
  <study_first_posted type="Actual">January 5, 2021</study_first_posted>
  <last_update_submitted>March 17, 2021</last_update_submitted>
  <last_update_submitted_qc>March 17, 2021</last_update_submitted_qc>
  <last_update_posted type="Actual">March 18, 2021</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>The Second Hospital of Hebei Medical University</investigator_affiliation>
    <investigator_full_name>Ruiqin xie</investigator_full_name>
    <investigator_title>Director of the Department of Cardiology in the Second Hospital of Hebei Medical University</investigator_title>
  </responsible_party>
  <patient_data>
    <sharing_ipd>No</sharing_ipd>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

